Tafasitamab (Anti-CD19)

Ask the supplier | View on supplier's website

Tafasitamab (Anti-CD19) is an Fc-modified, humanized monoclonal antibody that binds to the human B-cell surface antigen CD19. It is used in combination with allogeneic NK cell therapy in treatment of B-cell non-Hodgkin's lymphoma. MW:145.5 KD.

Supplier	Selleck Chemicals
Product #	A2563
Sku #	A2563-1mg*25
Pricing	1mg*25, $5070.00

Feedback